MedPath

Effects of tumeric and Serrapeptase capsule on reducing pain and improve range of motion in patients with osteoarthritis of the knee

Phase 3
Recruiting
Conditions
knee osteoarthritis.
Osteoarthritis of knee
Registration Number
IRCT20140804018677N8
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

age>45y and having knee osteoarthritis according to American College of Rheumatology diagnostic criteria
Knee pain with at least three of the followings: age>50, morning stiffness<30 min, crepitation, bone tenderness at knee, knee bone enlargement, warmness or pain in addition to osteophyte according to radiography
Grade 2 or 3 of osteoarthritis according to Kellgren and Lawrence system
Pain intensity between 5-8 at baseline according to Visual analog scale-VAS
Able to walk independently

Exclusion Criteria

not having joint arteritis, orthopedic or severe cardiovascular diseases
intra-articular injection of corticosteroids in past 3 months, as well as gel, and Platelet-rich plasma (PRP) in past year
Severe pain or allergic reaction during intervention that need for Nonsteroidal anti-inflammatory drugs (NSAIDs)
unable to complete the study
BMI>35

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Baseline and at the end of the study. Method of measurement: VAS (visual analog scale).;Range of Motion and stiffness. Timepoint: Baseline and at the end of the study. Method of measurement: Western Ontario and McMaster Universities Arthritis Index (WOMAC).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath